We are running this funding opportunity on the new UK Research and Innovation (UKRI) Funding Service so please ensure that your organisation is registered. You cannot apply on the Joint Electronic Submissions (Je-S) system.
The project lead is responsible for completing the application process on the Funding Service, but we expect all team members and project partners to contribute to the application.
Only the lead research organisation can submit an application to UKRI.
To apply
Select ‘Start application’ near the beginning of this Funding finder page.
- Confirm you are the project lead.
- Sign in or create a Funding Service account. To create an account, select your organisation, verify your email address, and set a password.
- Answer questions directly in the text boxes. You can save your answers and come back to complete them or work offline and return to copy and paste your answers. If we need you to upload a document, follow the upload instructions in the Funding Service. All questions and assessment criteria are listed in the How to apply section on this Funding finder page.
- Allow enough time to check your application in ‘read-only’ view before sending to your research office.
- Send the completed application to your research office for checking. They will return it to you if it needs editing.
- Your research office will submit the completed and checked application to UKRI.
Please be aware that research office and finance teams undertake checks on hosting arrangements and financial eligibility. The ultimate responsibility for ensuring compliance with all opportunity requirements lies with the applicant.
Where indicated, you can also demonstrate elements of your responses in visual form if relevant.
When including images, you must:
- provide a descriptive caption or legend for each image immediately underneath it in the text box (this must be outside the image and counts towards your word limit)
- insert each new image on a new line
- use files smaller than 5MB and in JPEG, JPG, JPE, JFI, JIF, JFIF, PNG, GIF, BMP or WEBP formatImages should only be used to convey important visual information that cannot easily be put into words. The following are not permitted, and your application will be rejected if you include:
- sentences or paragraphs of text
- tables
- excessive quantities of images
A few words are permitted where the image would lack clarity without the contextual words, such as a diagram, where text labels are required for an axis or graph column.
For more guidance on the Funding Service, see:
General use of hyperlinks
Applications should be self-contained. You should only use hyperlinks to link directly to reference information. You must not include links to web resources to extend your application. Assessors are not required to access links to conduct assessment or recommend a funding decision.
Generative artificial intelligence (AI)
Use of generative AI tools to prepare funding applications is permitted, however, caution should be applied.
For more information see our policy on the use of generative AI in application and assessment.
Deadline
MRC must receive your application by 5 November 2026 4:00pm UK time.
You will not be able to apply after this time.
Make sure you are aware of and follow any internal institutional deadlines.
Following the submission of your application to this funding opportunity, your application cannot be changed, and submitted applications will not be amended. If your application does not follow the guidance, it may be rejected.
Personal data
Processing personal data
MRC as part of UKRI, will need to collect some personal information to manage your Funding Service account and the registration of your funding applications.
We will handle personal data in line with UK data protection legislation and manage it securely. For more information, including how to exercise your rights, read our privacy notice.
Sensitive information
If you or a core team member need to tell us something you wish to remain confidential, email PPexpmed@mrc.ukri.org
Include in the subject line: [the funding opportunity title; sensitive information; your Funding Service application number].
Typical examples of confidential information include:
- individual is unavailable until a certain date (for example due to parental leave)
- declaration of interest
- additional information about eligibility to apply that would not be appropriately shared in the ‘Applicant and team capability’ section
- conflict of interest for UKRI to consider in reviewer or panel participant selection
For information about how UKRI handles personal data, read UKRI’s privacy notice.
Institutional matched funding
There is no requirement for matched funding from the institutions hosting the project lead, project co-leads or other staff employed on the application, beyond the standard 20% FEC. Expert reviewers and panels assessing UKRI funding applications must not consider levels of institutional matched funding as a factor on which to base recommendations. Direct and in-kind contributions from third party project partners are encouraged.
This policy does not remove the need for support from host organisations who must provide the necessary research environment and infrastructure for award-specific activities funded by UKRI. For example, research facilities, training and development of staff.
Publication of outcomes
If your application is successful, we will publish some personal information on the UKRI Gateway to Research.
Summary
Word limit: 550
In plain English, provide a summary we can use to identify the most suitable experts to assess your application.
We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for example:
- opinion-formers
- policymakers
- the public
- the wider research community
Guidance for writing a summary
Clearly describe your proposed work in terms of:
- context
- the challenge the project addresses
- aims and objectives
- potential applications and benefits
Core team
List the key members of your team and assign them roles from the following:
- project lead (PL)
- project co-lead (UK) (PcL)
- project co-lead (international) (PcL (I))
- specialist
- grant manager
- professional enabling staff
- research and innovation associate
- technician
- visiting researcher
- researcher co-lead (RcL)
Only list one individual as project lead. If you include more than one project lead your application will fail at the checking stage.
UKRI has introduced a new addition to the ‘Specialist’ role type. Public contributors such as people with lived experience can now be added to an application.
Find out more about UKRI’s core team roles in funding applications.
Application questions
Keywords
Word limit: 10
Provide up to five keywords that describe your application.
What the assessors are looking for in your response
Provide up to a maximum of five keywords including the health area, for example: mental health, engineering biology, environmental health, diagnosis, obesity, vaccine development.
Use commas or spaces to distinguish individual terms or phrases.
This is for administrative purposes to help with the initial application processing and will not affect the overall assessment or influence the outcome of your application.
Vision
Word limit: 1,100
What are you hoping to achieve with your proposed work?
What the assessors are looking for in your response
Explain how your proposed work:
- aligns to the aims of the funding opportunity
- is of excellent quality and importance within or beyond the field(s) or area(s)
- has the potential to advance current understanding, or generate new knowledge, thinking or discovery in the context of precision prevention
- is timely given current trends, context, and needs
- impacts world-leading research, society, the economy, or the environment
Within the Vision section we also expect you to:
- provide details of the current clinical challenge or knowledge gap
- summarise the current state of understanding about the relevant mechanisms of disease
- identify the current gap in mechanistic understanding
- state the mechanistic hypothesis to be tested, which will generate mechanistic insights which would allow tailoring, targeting, and optimisation of existing prevention interventions or the development of new ones
- identify the potential direct or indirect benefits and who the beneficiaries might be
- identify potential improvements in human health, whether through contributing to preventing disease progression, relieving disease or disability burden, improving quality of life or providing benefit to the health service or health-related industry
- if applicable, describe the route to patient benefit
- explain if the results will be valuable for discovery science through ‘reverse translation’
References may be included within this section.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
Intervention
Word limit: 550
What is the planned biomedical intervention?
What the assessors are looking for in your response
Explain the planned intervention to be used in the proposed work, including:
- the type of intervention, which must be biomedical such as for example, pharmacological or immunological
- relevant background information, including its established safety profile and use in other mechanistic studies
- if applicable, summarise the development history of the intervention
- if applicable, provide details of any existing intellectual property (IP) associated with this intervention
References may be included throughout the intervention section.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
Approach
Word limit: 3,500
How are you going to deliver your proposed work?
What the assessors are looking for in your response
Within the Approach section we expect you to provide a detailed and comprehensive project plan, including timelines in the form of an embedded Gantt chart or similar, including:
- the objectives of the proposed research in order of priority
- the primary and secondary experimental outcomes and how they relate to the experimental objectives
- how the proposed work packages will ensure the project objectives are achieved
- your explanation of how your approach is effective and appropriate to achieve your objectives
Please ensure that the provided Gantt chart is legible and includes:
- project tasks (these being short, achievable and measurable activities) with, where relevant, the party responsible for delivering the task and dependency relationships between tasks
- at least two progression milestones (to include the project end goal), these being major specifically-timed decision points
Within the Approach section, we also expect you to provide details on the proposed methodology and experimental design, including:
- the experiments you will undertake to probe the stated hypothesis
- the data you will collect and how it will test the hypothesis
- the proposed trial design and why this approach is appropriate to meet the study objectives
As part of your methodology, describe the nature of human participation in your proposed work, including:
- the characteristics of the participants (such as age, disease) and the rationale for their selection
- the specific population groups in relation to their diversity characteristics and the proposed analysis, following the MRC embedding diversity in research design policy
- target and acceptable levels of participant recruitment across the project timeline
- evidence of recruitment feasibility
- the human participant recruitment strategy, including the steps that will be taken if patient recruitment does not reach the set targets
- describe your approach to ethical and regulatory approvals and their status. Consider the MRC guidance on ethics and approvals
- if applicable, provide details of how any limited tissue or cell work will inform the human-centric proposed work and provide the name of any required approving body and whether approval is already in place. For any research involving tissues and cells, you must show how you will use male and female donors. If you are not proposing to do this, a strong justification is required
- if applicable, explain the inclusion of public and patient partnerships and the added value these offer
Demonstrate that your proposed approach is feasible, and comprehensively identify any risks to delivery and how they will be managed, including:
- how likely the risks are to occur
- what their impact would be on the success and deliverability of the project
- your risk mitigation strategy, giving particular consideration to any potential safety risks and how these risks will be controlled
- you may include a risk table to support your response
Describe how your, and if applicable your team’s, research environment (in terms of the place and relevance to the project) will contribute to the success of the work.
Demonstrate access to the appropriate services, facilities, infrastructure, or equipment to deliver the proposed work, including:
- specialist equipment or infrastructure required to deliver the project objectives
- proposed use of existing joint research facilities or clinical infrastructure, for example Experimental Cancer Medicine Centres, NIHR Biomedical Research Centres, NIHR Clinical Research Facilities, including patient cohorts
- if not already in place, explain how you will ensure this infrastructure is accessible by the project start date
- describe how the approach builds on existing scientific, technical and clinical expertise and clinical research infrastructure, the nature of existing partnerships and the value these add
Describe how you will maximise translation of outputs into outcomes and impacts through your plans for engagement, communication and dissemination with:
- the research community
- industry
- patients and the public
We suggest you structure your response using the following headings, with approximate words limits for each:
- project plan: 1,650 words
- methodology and experimental design: 850 words
- risk management: 400 words
- infrastructure and equipment: 400 words
- engagement, communication and dissemination: 200 words
References may be included throughout the approach section.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
You should detail any information regarding your statistical design in the ‘Reproducibility and statistical design’ section.
Reproducibility and statistical design
Word limit: 500
How will you ensure your proposed work is reliable, robust and reproducible?
What assessors are looking for in your response
Information about reproducibility and how you will ensure reliability and robustness of your proposed work, such as further details of statistical analyses, methodology and experimental design, not provided in your approach.
We expect you to seek professional statistical or other relevant advice in preparing your response, which should include, as appropriate:
- sample and effect sizes
- planned statistical analyses
- models chosen (for example animal model, cell line)
- potential sources of bias and how these will be mitigated during analysis
- how your approach to addressing diversity is reflected in the experimental design and analyses
Refer to the MRC guidance for applicants, for further information, examples and online tools.
If your proposed work involves animals, and you provide information on animal sample sizes and statistical analyses here, you should not duplicate it in the ‘Animal involvement and “3Rs”’ section. Use the ‘Animal involvement and “3Rs”’ section to provide information on the rationale for using animals, choice of species, welfare and procedure severity.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
The length of your response will vary depending on the type of project, you may not need to use 500 words.
Project milestones
Word limit: 1,500
Provide details of your project milestones.
What the assessors are looking for in your response
Provide at least two key progression milestones that will:
- delineate the proposed work into costed project phases with clear go or no-go decision points
- establish success criteria with target and acceptable thresholds
Milestones are key points within the project lifecycle where progress is assessed before moving on to the next phase. While project tasks and work packages may run concurrently across different milestones, the milestones themselves must not overlap and must occur at distinct, sequential timepoints.
Milestones must be SMART (specific, measurable, achievable, relevant, and time-framed). They should:
- detail robust go or no-go criteria (failure to meet these will result in early termination of the project)
- be structured so that critical questions are addressed as early as possible in the plan
Success criteria should be based on project outputs that must be achieved at that point, to justify continuing the work. Success criteria should align to project aims and objectives. For the final milestone: success criteria should reflect what would constitute success for the funded aspect of your project.
For each success criterion, specify:
- a quantified target value you aim to achieve
- a quantified acceptable value, which, if achieved, would still support project progression
A brief justification should be provided for the criteria and values selected, explaining why they are suitable for assessing progress at this point in the project. Note that target and acceptable values must be achieved at the same timepoint and that milestones must be sequential.
Do not include project management meetings or other process-related tasks as milestone success criteria.
For clinical studies, you must provide a summary of:
- study design
- study participants
- study endpoints
- dose (if applicable)
- analysis plans
These elements must be directly linked to clear success criteria with defined target and acceptable values.
Additional guidance will be provided in the Funding Service on how to complete this section, including the required format.
For each milestone, using the table format, provide the following details:
- duration (in months) from project start and from the previous milestone (not applicable for the first milestone, Milestone one)
- milestone full economic costing (FEC) and cumulative FEC from project start
- likelihood of meeting the milestone’s criteria
- objectives
- measurable success criteria with target and minimum acceptable values for each criterion, along with a justification for these choices
You may include a minimum of two milestones and as many additional milestones as needed for your project.
Data management and sharing
Word limit: 1,500
How will you manage and share data collected or acquired through the proposed research?
What the assessors are looking for in your response
Provide a data management plan which should clearly detail how you will comply with MRC’s published data management and sharing policies, which includes detailed guidance notes.
Provide your response in the text box following the headings in the MRC data management plan template. You are not required to upload the document to your application.
The length of your plan will vary depending on the type of study being undertaken:
- population cohorts; longitudinal studies; genetic, omics and imaging data; biobanks, and other collections that are potentially a rich resource for the wider research community: maximum of 1,500 words
- all other research, less complex, the plan may be as short as 500 words
Applicant and team capability to deliver
Word limit: 2,200
Why are you the right individual or team to successfully deliver the proposed work?
What the assessors are looking for in your response
Evidence of how you, and if relevant your team, have:
- the relevant experience (appropriate to career stage) to deliver the proposed work
- the right balance of skills and expertise to cover the proposed work
- the appropriate leadership and management skills to deliver the work and your approach to develop others
- contributed to developing a positive research environment and wider community
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
The word limit for this section is 2,200 words: 1,700 words to be used for Résumé for Research and Innovation (R4RI) modules (including references) and, if necessary, a further 500 words for Additions.
Use the R4RI format to showcase the range of relevant skills you and, if relevant, your team (project lead and project co-leads, researchers, technicians, specialists, partners and so on) have and how this will help deliver the proposed work. You can include individuals’ specific achievements but only choose past contributions that best evidence their ability to deliver this work.
Complete this section using the R4RI module headings listed. Use each heading once and include a response for the whole team, see the UKRI guidance on R4RI. You should consider how to balance your answer, and emphasise where appropriate the key skills each team member brings:
- contributions to the generation of new ideas, tools, methodologies, or knowledge, this may include your previous funding and key outputs such as publications
- the development of others and maintenance of effective working relationships
- contributions to the wider research and innovation community
- contributions to broader research or innovation users and audiences and towards wider societal benefit, including public partnerships
Additions
Provide any further details relevant to your application. This section is optional and can be up to 500 words. You should not use it to describe additional skills, experiences, or outputs, but you can use it to describe any factors that provide context for the rest of your R4RI (for example, details of career breaks if you wish to disclose them).
Complete this as a narrative. Do not format it like a CV.
References may be included within this section.
The roles in funding applications policy has descriptions of the different project roles.
Project partners
You must add details about your project partner(s) contributions to this section.
A project partner is a collaborating third party organisation who will have an integral role in the proposed research. This may include direct (cash) or indirect (in-kind) contributions such as expertise, staff time or use of facilities. Project partners may be in industry, academia, third sector or government organisations in the UK or overseas, including partners based in the EU.
This funding opportunity requires at least one industry or company partnership. Applications that do not include an industry or company project partner will be rejected. Therefore, you will also need to complete the ‘Industry Collaboration Framework (ICF)’ section. Find out more about ICF.
You must ensure that any third party individual or organisation you include within the Funding Service as a project partner, also provides you with a supporting email or letter of support (see next section ‘Project partners: letters or emails of support’).
The individual named as the project partner contact, cannot be included in your application as a member of the core team, in any core team role.
The project partner organisation cannot be an applicant organisation, where any member of the core team is based. For example, you cannot include a different department based within the applicant organisation as a project partner.
If an individual or organisation outside the core team is responsible for recruitment of people as research participants or providing human tissue for this project, list them as a project partner.
Add the following project partner details:
- the organisation name (searchable via a drop-down list or enter the organisation’s details manually, as applicable)
- the project partner contact name and email address
- the type of contribution (direct or in-direct) and its monetary value
If there are specific circumstances where project partners do require funding for minor costs such as travel and subsistence, these project partner costs should be claimed and justified within the resources and costs section of your application.
If a detail is entered incorrectly and you have saved the entry, remove the specific project partner record and re-add it with the correct information.
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made.
Project partners: letters (or emails) of support
Upload a single PDF containing the letters or emails of support from each partner you named in the ‘Project partners’ section. These should be uploaded in English or Welsh only.
What the assessors are looking for in your response
If you do not have any project partners, you will be able to indicate this in the Funding Service.
What supporting statements we are looking for
We are looking for you to provide letters or emails of support from all your identified project partners.
What we are not looking for
We don’t want any other letters (or emails) of support, from people who are not your identified project partners, such as those simply expressing general support for your project. If these are included by you, they will be ignored by us and will not be used in the assessment process.
Important information
You should only provide letters or emails of support from people you have identified in the project partner section of your application, who will have an integral role in your proposed research.
What each project partner letter or email of support must include
Each project partner letter or email you provide should:
- include the name of the project partner organisation and contact information
- explain the project partners’ commitment to the project
- explain the value, relevance, and possible benefits of the proposed work, to them
- describe any additional value they will bring to the project
- not exceed two sides of A4 per project partner
Project partner letters and emails of support are not required to be on headed paper or include handwritten signatures (electronic signatures are acceptable).
The Funding Service will provide document upload details when you apply.
Project partners from industry or a company
Industry or company project partners are required to download and complete the industry or company letter of support template.
Project partners responsible for recruiting research participants or providing human tissue or samples
If the project partner is responsible for the recruitment of people as research participants or providing human tissue their letter or email of support should include:
- agreement that the project partner will recruit the participants or provide tissue
- confirmation that what is being supplied is suitable for the proposed work
- confirmation that the quantity of tissue being supplied is suitable, but not excessive for achieving meaningful results (if applicable)
Agreement with your project partners
Ensure you have prior agreement from project partners so that, if you are offered funding, they will support your project as indicated in the ‘Project partners’ section.
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made.
Industry Collaboration Framework (ICF)
Word limit: 1,500
Include details of your collaboration with your industry or company project partner(s)?
What the assessors are looking for in your response
The assessors are looking for you to confirm that your proposed work involves collaboration with an industry or company project partner. You will need to follow the MRC Industry Collaboration Framework (ICF).
By ‘industry or company’ we mean an enterprise that puts or has intention to put goods or services on a market.
You should explore the ICF decision tree and find out more about ICF which includes:
- collaboration agreements
- definitions of basic or applied research
- internationally based companies
- subsidy control
- intellectual property (IP) arrangements
- fully flexible and gated contributions
- the ICF assessment criteria
Enter ‘Yes’ in the text box that you have industry or company project partners and you are likely to follow ICF. You should also confirm you’re answers to the ICF questions one to nine in the text box for each ICF project partner.
Contact PPexpmed@mrc.ukri.org if you are unsure if your application should follow ICF.
In addition to the project partner information completed in the previous section, the assessors are looking for information relating to the nature, goals and conditions of the collaboration and any restrictions or rights to the project results that could be claimed by the industry or company project partner.
Confirm your answers to the ICF questions in the text box, repeat this process for each ICF project partner:
- Name the industry or company project partner considered under ICF.
- Indicate whether your application is basic research or applied research.
- Explain why, in the absence of the requested UKRI funding, the collaboration and the planned research could not be undertaken.
- State whether your application is under the category of fully flexible contribution or gated contribution (based on the IP sharing arrangements with the industry or company).
- Outline the pre-existing IP (‘background IP’) that each partner, including the academic partner, will bring to the collaborative research project and the terms under which partners may access these assets.
- Outline the IP that is expected to be developed during the collaborative research project (‘foreground IP’) and briefly outline how it will be managed, including:
- who will own this IP
- what rights industry or company partners will have to use academically-generated foreground IP during and after the research project, for internal research and development or for commercial purposes
- any rights of the academic partner to commercialise the foreground IP, including foreground IP generated by industry or company partners
- Outline any restrictions to dissemination of the project results, including the rights of the industry or company partner to:
- review, approve or delay publications (including the time period associated with such rights)
- request or require the removal of any information
- Declare any conflicts of interest held by the applicants in relation to the industry or company project partners and describe how they will be managed.
- Justify collaborating with an overseas industry or company under ICF (if applicable).
Failure to provide the information requested for industry or company partners under ICF could result in your application being rejected.
You are recommended to discuss the goals and conditions of any collaboration with an industry or company with your technology transfer or contracts office before applying.
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made. You must provide us with a copy of the collaboration agreement, signed by all partners, before an ICF award starts.
If this does not apply to your proposed work, you will be able to indicate this in the Funding Service.
Ethics and responsible research and innovation (RRI)
What are the ethical and RRI considerations, implications and issues relating to the proposed work? If you do not think that the proposed work raises any ethical or RRI issues, explain why.
What the assessors are looking for in your response
Demonstrate that you have identified and evaluated:
- the relevant ethical and RRI considerations, including both the research or topic area itself and the design and delivery of the project
- the wider implications of the proposed work, and how you will maximise the positive societal, environmental, and economic benefits arising from the project, whilst minimising unintended negative impacts, such as research misuse or accidental harm
- how you will manage these considerations throughout the lifecycle of the project
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
Please refer to the UKRI position statement on funding ethical research and Responsible innovation for more information around our expectations on ethical and responsible research and innovation.
Animal involvement and “3Rs”
You must complete this section about how your proposed project will involve or impact animals.
If your project does not involve or impact animals, you must confirm this on the next page.
You may be asked about:
- what animals you are involving
- the severity of the procedures you are using
- where the procedures will take place
- welfare standards you aim to meet
- the relevance of your project to the development, validation or dissemination of the 3Rs
You may also need to download, complete, and upload at least one set of additional questions. You will be told how to do this towards the end of this section.
To complete this section and check whether your project is in the scope of the questions, refer to the UKRI policy on research and innovation involving animals.
What counts as an animal
UKRI policy relates to all animals in the Kingdom Animalia, including vertebrates and invertebrates.
Genetically modified organisms and biological risk
You must complete this section if your project will include genetically modified organisms or genetic technologies.
If you project does not involve genetically modified organisms or genetic technologies, you must confirm this on the next page.
You may be asked about:
- the type of organism your project will involve and the procedures your project will include
- the intended use of the organism or genetic technology
- the genetic, biological and environmental risks of your project
For more information, see UKRI’s guidance on genetic technologies.
Human participation in health-related research
You must complete this section about whether your project will include human participation.
If your project does not involve human participation, you must confirm this on the next page.
You may be asked about:
- what type of human participation your project includes
- the project design for human participation
- the phase of the clinical trial
- whether the project will be in an NHS setting, if so how the project will be registered
- whether diversity and inclusion will be considered
For more information, see UKRI’s guidance for human participants in research.
Resources and cost justification
Word limit: 1,000
What will you need to deliver your proposed work and how much will it cost?
What the assessors are looking for in your response
Justify the application’s more costly resources, in particular:
- project staff
- significant travel for field work or collaboration (but not regular travel between collaborating organisations or to conferences)
- any equipment that will cost more than £25,000
- any consumables beyond typical requirements, or that are required in exceptional quantities
- all facilities and infrastructure costs
- all resources that have been costed as ‘Exceptions’
- support for international co-leads, demonstrating this is within the 30% costs cap for co-leads from high-income countries, India and China. There is no cap on costs requested for international applicants from DAC list countries
- NHS research costs, when they are associated with NHS studies
- any work to be outsourced, including the reason for outsourcing, scope, provider and cost
- support for public and patient involvement and engagement. See payments to public partners
You can request costs associated with reasonable adjustments where they increase as a direct result of working on the project. For further information see Disability and accessibility support for UKRI applicants and grant holders. Where a funding limit is imposed on the opportunity, requested costs for reasonable adjustments may exceed the maximum funding amount.
Assessors are not looking for detailed costs or a line-by-line breakdown of all project resources. Overall, they want you to demonstrate how the resources you anticipate needing for your proposed work:
- are comprehensive, appropriate, and justified
- represent the optimal use of resources to achieve the intended outcomes
- maximise potential outcomes and impacts
Trusted Research and Innovation (TR&I)
Trusted Research and Innovation is the protection of the UK’s intellectual property, sensitive research, people, and infrastructure from potential theft, misuse, and exploitation.
Organisations receiving UKRI funding are obliged to act in line with UK government legislation. They are also expected to undertake appropriate due diligence assessments of organisations involved in research partnerships, collaboration agreements, and commercial contracts.
You will be asked about:
- which areas of the National Security and Investment (NSI) Act your project relates to
- who you intend to collaborate with and how
- if your project requires an export control licence
Your answers may affect the T&Cs of your funding agreement if you are successful. We may use your answers to determine that our current T&Cs are sufficient or if additional T&Cs are required.
